The Global Diabetes Associated Ophthalmic Treatment Market accounted for US$ 26.14 Bn in 2020 with a considerable CAGR of 6% during the forecast period of 2022 to 2028. Diabetes-related eye diseases have generated tremendous interest from primary care providers and the large medical community engaged in classification, diagnosis and treatment. The economic, social and health-related global burden of diabetes is […]
